Compare Emerson Electric Co. (EMR) vs Manhattan Associates Inc (MANH) Price & Performance

Emerson Electric (EMR) trades at $137.06, up 0.7% on the day, with a bearish technical signal but strong analyst support. Recent earnings have mostly beaten expectations, with Q2 2026 results pending. The company maintains solid profitability with a 13.35% net income margin and a consensus price target of $157.60, suggesting 15% upside. Cash flow trends show operational strength despite net outflows, and a dividend of $0.56 was recently declared.

EMR presents a mixed outlook: bullish fundamentals and analyst ratings contrast with near-term technical weakness. Investment appeal hinges on earnings execution and sector momentum, while risks include debt levels and market volatility. The stock's valuation at a P/E of 31.54 requires sustained growth to justify further gains.

MANH trades at $156.66, down 1.22% today, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust profitability with 56% gross margins and 19.68% net income margins, though valuations appear elevated with a P/E of 43.85. Recent earnings have consistently beaten expectations, with Q1 2026 EPS of $1.24 surpassing the $1.10 estimate. However, ongoing legal investigations into fiduciary duties create investor uncertainty.

The outlook remains positive with analyst consensus at Buy (73%) and a $192.80 price target suggesting 23% upside. Key risks include high valuation multiples, legal investigations, and potential execution challenges in cloud transition. Earnings growth and AI initiatives provide catalysts, but investors should weigh premium valuation against legal overhang.